Fate Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 02/17/2026 | 12.87 M | $12.65 M | 0.00% | 10.82% |
| BLACKROCK, INC. | 02/12/2026 | 10.18 M | $10.00 M | -4.72% | 8.55% |
| VANGUARD GROUP INC | 01/29/2026 | 8.97 M | $8.82 M | 1.96% | 7.54% |
| JOHNSON & JOHNSON | 03/18/2026 | 3.38 M | $3.32 M | 0.00% | 2.84% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 2.93 M | $2.88 M | 8.18% | 2.46% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.47 M | $2.43 M | -2.45% | 2.07% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.36 M | $2.32 M | 87.00% | 1.98% |
| STATE STREET CORP | 02/13/2026 | 2.27 M | $2.23 M | -6.29% | 1.90% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.73 M | $1.70 M | 92.51% | 1.46% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 1.73 M | $1.69 M | -31.41% | 1.45% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.65 M | $1.62 M | 63.96% | 1.39% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.58 M | $1.55 M | -24.70% | 1.33% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.53 M | $1.50 M | 100.00% | 1.28% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.44 M | $1.41 M | -3.46% | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.17 M | $1.15 M | -37.48% | 0.98% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.16 M | $1.14 M | 2.70% | 0.98% |
| MORGAN STANLEY | 02/13/2026 | 916.95 K | $900.99 K | -1.40% | 0.77% |
| JANE STREET GROUP, LLC | 02/12/2026 | 842.81 K | $828.14 K | 39.59% | 0.71% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2026 | 830.00 K | $815.56 K | 7.79% | 0.70% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 784.63 K | $770.98 K | -0.16% | 0.66% |
| CITADEL ADVISORS LLC | 02/17/2026 | 749.34 K | $736.30 K | -9.12% | 0.63% |
| NORTHERN TRUST CORP | 02/17/2026 | 732.67 K | $719.92 K | -10.04% | 0.62% |
| BRUCE & CO., INC. | 02/13/2026 | 729.19 K | $716.50 K | 0.00% | 0.61% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 550.00 K | $540.43 K | 100.00% | 0.46% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 522.62 K | $513.52 K | -45.78% | 0.44% |
| UBS GROUP AG | 01/29/2026 | 403.52 K | $396.66 K | 28.20% | 0.34% |
| INVESCO LTD. | 02/19/2026 | 379.03 K | $372.43 K | 20.39% | 0.32% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 369.10 K | $362.68 K | 10.77% | 0.31% |
| KNOTT DAVID M JR | 02/12/2026 | 365.00 K | $358.65 K | 0.00% | 0.31% |
| XTX TOPCO LTD | 02/17/2026 | 364.74 K | $358.39 K | -16.71% | 0.31% |
| WOODLINE PARTNERS LP | 02/17/2026 | 356.65 K | $350.44 K | -49.95% | 0.30% |
| NUVEEN, LLC | 02/12/2026 | 336.87 K | $331.01 K | 0.00% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 310.19 K | $304.79 K | 73.36% | 0.26% |
| BARCLAYS PLC | 02/13/2026 | 308.54 K | $303.17 K | 46.58% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 307.60 K | $302.25 K | -2.76% | 0.26% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 298.08 K | $292.90 K | -21.01% | 0.25% |
| MAN GROUP PLC | 02/17/2026 | 261.17 K | $256.63 K | 18.90% | 0.22% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 213.65 K | $210.00 K | -31.27% | 0.18% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 195.58 K | $192.18 K | -58.31% | 0.16% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 192.68 K | $189.33 K | -64.62% | 0.16% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 187.70 K | $184.43 K | 0.00% | 0.16% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 172.28 K | $169.29 K | 28.72% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 151.11 K | $148.39 K | 3.11% | 0.13% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 148.65 K | $146.07 K | 1.93% | 0.12% |
| RHUMBLINE ADVISERS | 02/13/2026 | 146.76 K | $144.25 K | -4.75% | 0.12% |
| LPL FINANCIAL LLC | 02/11/2026 | 144.82 K | $142.30 K | 505.52% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 135.00 K | $132.65 K | 35.00% | 0.11% |
| IEQ CAPITAL, LLC | 02/13/2026 | 121.50 K | $119.39 K | -11.67% | 0.10% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 111.23 K | $109.29 K | 100.00% | 0.09% |
| HSBC HOLDINGS PLC | 03/20/2026 | 97.68 K | $96.24 K | -0.12% | 0.08% |
Fate Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 230 institutional investors and hedge funds held shares of Fate Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 1.82 M
DIMENSIONAL FUND ADVISORS LP: 883,790
Monaco Asset Management SAM: 810,000
VANGUARD FIDUCIARY TRUST CO: 653,761
JANE STREET GROUP, LLC: 646,979
Connor, Clark & Lunn Investment Management Ltd.: 469,785
60.51% of Fate Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 106.57 M shares in the last 24 months. This purchase volume represents approximately $141.74 M in transactions.